Novartis's Gilenya Reviewed by EU After 11 Patient Deaths - Bloomberg

Bloomberg

Novartis's Gilenya Reviewed by EU After 11 Patient Deaths Bloomberg The reports raise concern that Gilenya, the first oral treatment for the debilitating neurological disease, may harm the heart, the European Medicines Agency said in a statement today. The US Food and Drug Administration said it's also reviewing data ... and more »

Birth control pills relieve menstrual pain - Food Consumer

Birth control pills relieve menstrual pain Food Consumer The study published on Tuesday in the journal Human Reproduction examined survey data on women, which were collected over a 30 year period to determine whether a combination of oral contraception pills alleviate symptoms of painful menstrual periods, ... and more »

Victoza sales double as Novo Nordisk profits soar - Pharma Times

Victoza sales double as Novo Nordisk profits soar Pharma Times However, human insulins were down 7% to 2.79 billion kroner, while oral antidiabetic products, notably NovoNorm/Prandin (repaglinide), fell 3% to 649 million kroner. As for Victoza (liraglutide), sales of Novo's once-daily human glucagon-like peptide-1 ... Victoza sales boost Novo NordiskThe Pharma Letter all 135 news articles »

New Actavis / Bioton alliance to shake up diabetes market - Reuters

New Actavis / Bioton alliance to shake up diabetes market Reuters The remainder (EUR 33.25 million) will be paid in instalments in accordance with agreed milestones relating to the registration process involving recombined human insulin (RHI). Based on the sales volumes estimated by the parties, Actavis' revenues ... and more »

Curing the Incurable - Assam Times (blog)

Curing the Incurable Assam Times (blog) It can start form anywhere in the human body and can spread to any part. It does not discriminate regarding religion, age, gender, region or color. Over 1 million cases of cancer are detected every year in India. It is one of the common health hazard ... and more »